BLMS (Bloomios) Accounts Receivable : $0.34 Mil (As of Sep. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Bloomios Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Bloomios's accounts receivables for the quarter that ended in Sep. 2023 was $0.34 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Bloomios's Days Sales Outstanding for the quarter that ended in Sep. 2023 was 46.03.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Bloomios's Net-Net Working Capital per share for the quarter that ended in Sep. 2023 was $-0.68.

Bloomios Accounts Receivable Historical Data

The historical data trend for Bloomios's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bloomios Accounts Receivable Chart

Bloomios Annual Data

Trend

Jun02

Jun03

Jun04

Jan05

Jan06

Jan07

Jan19

Jan20

Dec21

Dec22

Accounts Receivable

Get a 7-Day Free Trial

0.06

0.53

Bloomios Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Accounts Receivable	Get a 7-Day Free Trial															0.08	0.53	0.56	0.30	0.34

Bloomios Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Bloomios Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Bloomios's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.344	/	0.682	*	91
=	46.03

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Bloomios's accounts receivable are only considered to be worth 75% of book value:

Bloomios's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0	+	0.75 * 0.344	+	0.5 * 0	-	33.397
-	8.5	-	0)	/	61.4733
=	-0.68

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Bloomios Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Bloomios's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Bloomios Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bloomios Inc (OTCPK:BLMS) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

701 Anacapa Street, Suite C, Santa Barbara, CA, USA, 93101

Website

https://www.bloomios.com

Bloomios Inc manufactures, markets, and distributes U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States of America. It offers its private-label and white-label customers large collections of customizable hemp products that include over 80 products across 7 categories in addition to custom formulation and manufacturing services. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats.

Executives

Douglas S Rohrer	officer: Chief Business Officer	701 ANACAPA, SUITE C, SANTA BARBARA CA 93101
Emc2 Capital Llc	10 percent owner	201 W MONTECITO STREET, SANTA BARBARA CA 93101
Barrett Evans	director, 10 percent owner, officer: Pres, Chief Strategy Officer
Aline Hayuta Elkayam	10 percent owner	104 CHELSEA PLACE, ORMOND BEACH FL 32174
Bibi Daprile	10 percent owner	12 WINDING CREEK WAY, ORMOND BEACH FL 32174
Agpl Acquisition, Inc	10 percent owner	201 W MONTECITO ST., SANTA BARBARA CA 93101
Mammoth Crest Capital Llc	10 percent owner	1712 PIONEER AVE, SUITE 558, CHEYENNE WY 82001
Michael Hill	director, 10 percent owner, officer: Chief Executive Officer	201 WEST MONTECITO STREET, SANTA BARBARA CA 93101
Bryan Glass	director, 10 percent owner, officer: President and Director	20 WEST PARK AVENUE, SUITE 207, LONG BEACH NY 11561
Douglas Boyd	director, officer: Chairman of the Board	8101 TIARA COVE CIR, LAS VEGAS NV 89128
Peter A Hogendoorn	director, officer: President & CEO	13288 AMBLE GREEN PLACE, SURREY A1 V4A 6P5
Harold C Moll	director, 10 percent owner
Van Laare Derek R	officer: Secretary	6119 GORDON AVENUE, BURNABY A1 V5E 3M2
Carlo Civelli	other: former director/officer/owner	111 SOMERSET ROAD, TRIPLE ONE SOMERSET 06-06, SINGAPORE U0 238164
Logan Anderson	director, officer: President & Treasurer	15 HILL CRESCENT, PEMBROKE BERMUDA D8 00000